Page last updated: 2024-08-16

temozolomide and ml 00253764

temozolomide has been researched along with ml 00253764 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bocci, G; Di Desidero, T; Giuliani, D; Guarini, S; Orlandi, P; Ottani, A; Pacini, S; Pardini, C; Pasqualetti, F; Vaglini, F	1

Other Studies

1 other study(ies) available for temozolomide and ml 00253764

Article	Year
Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo. Molecular neurobiology, 2018, Volume: 55, Issue:6 Topics: Animals; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Glioblastoma; Humans; Imidazoles; Mice; Mice, Nude; Neurons; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Melanocortin, Type 4; Temozolomide	2018

Article

Year

Melanocortin Receptor-4 and Glioblastoma Cells: Effects of the Selective Antagonist ML00253764 Alone and in Combination with Temozolomide In Vitro and In Vivo.

Molecular neurobiology, 2018, Volume: 55, Issue:6

Topics: Animals; Apoptosis; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Glioblastoma; Humans; Imidazoles; Mice; Mice, Nude; Neurons; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, Melanocortin, Type 4; Temozolomide

2018